Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Metabolic abnormalities associated with HIV infection and antiretroviral therapy.

Fichtenbaum CJ.

Curr Infect Dis Rep. 2009 Jan;11(1):84-92.

PMID:
19094829
2.

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS; International AIDS Society-USA..

J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):257-75. Review.

PMID:
12439201
3.

Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection.

Heath KV, Montaner JS, Bondy G, Singer J, O'Shaughnessy MV, Hogg RS.

Curr Drug Targets. 2003 Jan;4(1):13-22. Review.

PMID:
12528986
4.
5.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
6.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
7.

Metabolic complications associated with HIV protease inhibitor therapy.

Nolan D.

Drugs. 2003;63(23):2555-74. Review.

PMID:
14636077
8.

HIV and HIV treatment: effects on fats, glucose and lipids.

Gkrania-Klotsas E, Klotsas AE.

Br Med Bull. 2007;84:49-68. Review.

PMID:
17981955
9.

Antiretroviral therapy: an update for the non-AIDS specialist.

Kalkut G.

Curr Opin Oncol. 2005 Sep;17(5):479-84. Review.

PMID:
16093800
10.

Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.

Moreno S, Hernández B, Dronda F.

Drugs. 2007;67(10):1441-62. Review.

PMID:
17600392
11.

HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.

Kotler DP.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S79-85. doi: 10.1097/QAI.0b013e318186519c. Review.

PMID:
18725816
12.
13.

Metabolic complications of antiretroviral therapy.

Sweet DE.

Top HIV Med. 2005 Jun-Jul;13(2):70-4. Review.

14.

Diagnosis and management of common chronic metabolic complications in HIV-infected patients.

Bader MS, Kelly DV.

Postgrad Med. 2008 Nov;120(4):17-27. doi: 10.3810/pgm.2008.11.1930. Review.

PMID:
19020362
15.
16.

The metabolic puzzle during the evolution of HIV infection.

Salas-Salvadó J, García-Lorda P.

Clin Nutr. 2001 Oct;20(5):379-91. Review.

PMID:
11534932
17.
19.
20.

HIV disease and advanced age: an increasing therapeutic challenge.

Manfredi R.

Drugs Aging. 2002;19(9):647-69. Review.

PMID:
12381235

Supplemental Content

Support Center